LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article ; Online: Association of Fructosamine Levels with Glycemic Control in Children with Type 1 Diabetes as Determined by Continuous Glucose Monitoring: Results from the CGM TIME Trial.

    Verbeeten, Kate C / Tang, Ken / Courtney, Jennilea M / Bradley, Brenda J / McAssey, Karen / Clarson, Cheril / Kirsch, Susan / Curtis, Jacqueline R / Mahmud, Farid H / Richardson, Christine / Cooper, Tammy / Lawson, Margaret L

    Canadian journal of diabetes

    2024  

    Abstract: Objectives: To determine the correlation between fructosamine, used to assess glycemia when HbA1c is not appropriate, with average blood glucose as measured by continuous glucose monitoring (CGM) in children with type 1 diabetes.: Methods: 97 blood ... ...

    Abstract Objectives: To determine the correlation between fructosamine, used to assess glycemia when HbA1c is not appropriate, with average blood glucose as measured by continuous glucose monitoring (CGM) in children with type 1 diabetes.
    Methods: 97 blood samples were collected from 70 participants in the CGM TIME Trial. Each eligible participant had 3 weeks of CGM data with at least 60% CGM adherence prior to blood collection. Ordinary least squares linear regression incorporating restricted cubic splines was used to determine association between fructosamine and mean blood glucose.
    Results: An association was found between fructosamine levels and mean blood glucose with F-statistic of 9.543 p-value <0.001). Data were used to create formulae and a conversion chart for calculating mean blood glucose from fructosamine levels for clinical use.
    Conclusions: There is a complex relationship between average blood glucose and fructosamine.
    Language English
    Publishing date 2024-04-11
    Publishing country Canada
    Document type Journal Article
    ISSN 2352-3840
    ISSN (online) 2352-3840
    DOI 10.1016/j.jcjd.2024.04.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Motivational Stage at Continuous Glucose Monitoring (CGM) Initiation in Pediatric Type 1 Diabetes Is Associated With Current Glycemic Control but Does Not Predict Future CGM Adherence or Glycemic Control.

    Verbeeten, Kate C / Chan, Jason / Sourial, Nadia / Courtney, Jennilea M / Bradley, Brenda J / McAssey, Karen / Clarson, Cheril / Kirsch, Susan / Curtis, Jacqueline R / Mahmud, Farid H / Cooper, Tammy / Richardson, Christine / Lawson, Margaret L

    Canadian journal of diabetes

    2021  Volume 45, Issue 5, Page(s) 466–472.e4

    Abstract: Objectives: The Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (CGM TIME) Trial is a multicenter, randomized controlled trial in children with type 1 diabetes, comparing simultaneous pump and CGM with CGM ... ...

    Abstract Objectives: The Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (CGM TIME) Trial is a multicenter, randomized controlled trial in children with type 1 diabetes, comparing simultaneous pump and CGM with CGM initiation 6 months later (Paradigm, Veo, Enlite Sensor, Medtronic Canada). This study addresses the ability of SOCRATES (Stages Of Change Readiness And Treatment Eagerness Scale) to classify children and parents into distinct motivational stages and identify the stages' association with glycated hemoglobin (A1C) at trial entry and outcomes 6 months after CGM initiation.
    Methods: Ninety-eight of 99 eligible children 10 to 18 years of age and 137 of 141 eligible parents completed SOCRATES at trial entry and 6 months later. Parent-child agreement for motivational stage was determined by weighted kappa. Linear regression was used to examine association between motivational stage and i) A1C at trial entry and ii) change in A1C and CGM adherence 6 months after CGM initiation.
    Results: More than 87% of children and 88% of parents were classified into distinct motivational stages, with weak parent-child agreement. At trial entry, motivational stage was associated with A1C, which was 1.02% higher for children in the Action stage than in the Precontemplation stage (p<0.0001). When compared with children of parents in Precontemplation, A1C for children of parents in the Maintenance and Action stages were 0.83% (p=0.02) and 0.36% (p=0.048) higher, respectively. Precontemplation was associated with shorter diabetes duration. Motivational stage at CGM initiation did not predict change in A1C or CGM adherence 6 months later.
    Conclusions: SOCRATES can categorize children with type 1 diabetes and their parents into motivational stages. Although motivational stage was associated with glycemic control at trial entry, it did not predict future diabetes-related behaviour or A1C.
    MeSH term(s) Adolescent ; Blood Glucose Self-Monitoring/psychology ; Blood Glucose Self-Monitoring/statistics & numerical data ; Child ; Diabetes Mellitus, Type 1/therapy ; Female ; Follow-Up Studies ; Forecasting ; Glycemic Control/statistics & numerical data ; Humans ; Male ; Motivation ; Treatment Adherence and Compliance/statistics & numerical data
    Language English
    Publishing date 2021-04-21
    Publishing country Canada
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ISSN 2352-3840
    ISSN (online) 2352-3840
    DOI 10.1016/j.jcjd.2021.04.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Anorexia nervosa in a patient with congenital adrenal hyperplasia.

    Galle, Jennifer / Kirsch, Susan / Kaufman, Miriam

    Journal of pediatric endocrinology & metabolism : JPEM

    2013  Volume 26, Issue 1-2, Page(s) 167–172

    Abstract: Life stressors and hormonal dysregulation in the hypothalamic-pituitary-adrenal (HPA) axis are common factors that play a role in both anorexia nervosa (AN) and congenital adrenal hyperplasia (CAH). The complexity of combined CAH and AN on the HPA axis ... ...

    Abstract Life stressors and hormonal dysregulation in the hypothalamic-pituitary-adrenal (HPA) axis are common factors that play a role in both anorexia nervosa (AN) and congenital adrenal hyperplasia (CAH). The complexity of combined CAH and AN on the HPA axis has not, to our knowledge, been previously illustrated. We present a report of an adolescent with CAH who developed AN, requiring hospitalized management. We use this case to review the pathophysiology of CAH and AN as it relates to the stress response and hormonal dysregulation within the HPA axis. We then highlight the interplay between these conditions, and provide support to the theory that AN acts as a chronic stressor in patients with CAH, leading to HPA axis hyperactivity and elevated levels of androgen precursors. It is prudent for the medical team to monitor and modify CAH steroid dosing during the acute phase of AN, weaning appropriately with AN treatment success.
    MeSH term(s) Adolescent ; Adrenal Hyperplasia, Congenital/complications ; Adrenal Hyperplasia, Congenital/diagnosis ; Adrenal Hyperplasia, Congenital/drug therapy ; Anorexia Nervosa/complications ; Anorexia Nervosa/diagnosis ; Anorexia Nervosa/drug therapy ; Body Weight/drug effects ; Dose-Response Relationship, Drug ; Female ; Humans ; Hydrocortisone/administration & dosage ; Hydrocortisone/therapeutic use
    Chemical Substances Hydrocortisone (WI4X0X7BPJ)
    Language English
    Publishing date 2013
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 1231070-0
    ISSN 2191-0251 ; 0334-018X
    ISSN (online) 2191-0251
    ISSN 0334-018X
    DOI 10.1515/jpem-2012-0193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study.

    Deal, Cheri / Kirsch, Susan / Chanoine, Jean-Pierre / Lawrence, Sarah / Cummings, Elizabeth / Rosolowsky, Elizabeth T / Marks, Seth D / Jia, Nan / Child, Christopher J

    CMAJ open

    2018  Volume 6, Issue 3, Page(s) E372–E383

    Abstract: Background: Country-specific data on outcomes of treatment with recombinant human growth hormone are lacking. We present such data for children treated with growth hormone in Canada.: Methods: We describe characteristics and outcomes of 850 children ( ...

    Abstract Background: Country-specific data on outcomes of treatment with recombinant human growth hormone are lacking. We present such data for children treated with growth hormone in Canada.
    Methods: We describe characteristics and outcomes of 850 children (mean age at baseline 8.5 yr) treated with growth hormone constituting the Canadian cohort of the multinational phase IV prospective observational Genetics and Neuroendocrinology of Short-stature International Study (GeNeSIS). The diagnosis associated with short stature was as determined by the investigator. Auxological data were evaluated yearly until near-adult height. Adverse events were assessed in all growth-hormone-treated patients.
    Results: The diagnosis ascribed as the cause of short stature was growth hormone deficiency in 526 children (61.9%), predominantly organic rather than idiopathic, particularly congenital pituitary abnormalities and intracranial tumours. All diagnostic groups with sufficient patients for analysis had increased height velocity standard deviation score (SDS) and height SDS during growth hormone treatment. For patients who reached near-adult height (
    Interpretation: Growth hormone treatment was effective and had a good safety profile in Canadian children. Growth hormone dosages were lower than in the US and global GeNeSIS cohorts, and a greater proportion of treated Canadian children had organic growth hormone deficiency.
    Study registration: ClinicalTrials.gov, no. NCT01088412.
    Language English
    Publishing date 2018-09-10
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 2701622-5
    ISSN 2291-0026
    ISSN 2291-0026
    DOI 10.9778/cmajo.20180020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.

    Lawson, Margaret L / Verbeeten, Kate C / Courtney, Jennilea M / Bradley, Brenda J / McAssey, Karen / Clarson, Cheril / Kirsch, Susan / Curtis, Jacqueline R / Mahmud, Farid H / Richardson, Christine / Cooper, Tammy / Chan, Jason / Tang, Ken

    Pediatric diabetes

    2020  Volume 22, Issue 2, Page(s) 279–287

    Abstract: Objective: To determine whether timing of CGM initiation offering low glucose suspend (LGS) affects CGM adherence in children and youth starting insulin pump therapy.: Methods: A 5-site RCT of pump-naïve subjects (aged 5-18 years) with type 1 ... ...

    Abstract Objective: To determine whether timing of CGM initiation offering low glucose suspend (LGS) affects CGM adherence in children and youth starting insulin pump therapy.
    Methods: A 5-site RCT of pump-naïve subjects (aged 5-18 years) with type 1 diabetes (T1D) for at least 1 year compared simultaneous pump and CGM initiation offering LGS vs standard pump therapy with CGM initiation delayed for 6 months. Primary outcome was CGM adherence (hours per 28 days) (MiniMed™ Paradigm™ Veo™ system; CareLink Pro™ software) over 6 months after CGM initiation. Secondary outcome HbA1c was measured centrally. Linear mixed-models and ordinary least squares models were fitted to estimate effect of intervention, and covariates baseline age, T1D duration, HbA1c, gender, ethnicity, hypoglycemia history, clinical site, and association between CGM adherence and HbA1c.
    Results: The trial randomized 144/152 (95%) eligible subjects. Baseline mean age was 11.5 ± 3.3(SD) years, T1D duration 3.4 ± 3.1 years, and HbA1c 7.9 ± 0.9%. Six months after CGM initiation, adjusted mean difference in CGM adherence was 62.4 hours per 28 days greater in the Simultaneous Group compared to Delayed Group (P = .007). There was no difference in mean HbA1c at 6 months. However, for each 100 hours of CGM use per 28-day period, HbA1c was 0.39% (95% CI 0.10%-0.69%) lower. Higher CGM adherence was associated with reduced time with glucose >10 mmol/L (P < .001).
    Conclusion: CGM adherence was higher after 6 months when initiated at same time as pump therapy compared to starting CGM 6 months after pump therapy. Greater CGM adherence was associated with improved HbA1c.
    MeSH term(s) Adolescent ; Blood Glucose/metabolism ; Blood Glucose Self-Monitoring ; Child ; Child, Preschool ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/drug therapy ; Female ; Glycated Hemoglobin A/metabolism ; Humans ; Hypoglycemic Agents/administration & dosage ; Insulin/administration & dosage ; Insulin Infusion Systems ; Male ; Patient Compliance ; Time Factors
    Chemical Substances Blood Glucose ; Glycated Hemoglobin A ; Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2020-11-04
    Publishing country Denmark
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1502504-4
    ISSN 1399-5448 ; 1745-1426 ; 1399-543X
    ISSN (online) 1399-5448
    ISSN 1745-1426 ; 1399-543X
    DOI 10.1111/pedi.13144
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.

    Verbeeten, Kate C / Perez Trejo, Maria Esther / Tang, Ken / Chan, Jason / Courtney, Jennilea M / Bradley, Brenda J / McAssey, Karen / Clarson, Cheril / Kirsch, Susan / Curtis, Jacqueline R / Mahmud, Farid H / Richardson, Christine / Cooper, Tammy / Lawson, Margaret L

    Pediatric diabetes

    2020  Volume 22, Issue 2, Page(s) 288–293

    Abstract: To determine if pump therapy with continuous glucose monitoring offering low glucose suspend (LGS) decreases fear of hypoglycemia among children with type 1 diabetes and their parents. The CGM TIME trial is a multicenter randomized controlled trial that ... ...

    Abstract To determine if pump therapy with continuous glucose monitoring offering low glucose suspend (LGS) decreases fear of hypoglycemia among children with type 1 diabetes and their parents. The CGM TIME trial is a multicenter randomized controlled trial that enrolled 144 children with type 1 diabetes for at least 1 year (mean duration 3.4 ± 3.1 years) starting pump therapy (MiniMed™ Veo™, Medtronic Canada). CGM (MiniMed™ Enlite™ sensor) offering LGS was introduced simultaneously or delayed for 6 months. Hypoglycemia Fear Scale (HFS) was completed by children ≥10 years old and all parents, at study entry and 12 months later. Simultaneous and Delayed Group participants were combined for all analyses. Subscale scores were compared with paired t-tests, and individual items with paired Wilcoxon tests. Linear regression examined association with CGM adherence. 121/140 parents and 91/99 children ≥10 years had complete data. Mean Behavior subscale score decreased from 21.1 (SD 5.9) to 17.2 (SD 6.1) (p < .001) for children, and 20.7 (SD 7.5) to 17.4 (7.4) (p < .001) for parents. Mean Worry subscale score decreased from 17.9 (SD 11.9) to 11.9 (SD 11.4) (p < .001) for children, and 23.1 (SD 13.2) to 17.6 (SD 10.4) (p < .001) for parents. Median scores for 10/25 child items and 12/25 parent items were significantly lower at 12 months (p < .001). Linear regression found no association between HFS scores and CGM adherence. Insulin pump therapy with CGM offering LGS significantly reduced fear of hypoglycemia not related to CGM adherence in children with type 1 diabetes and their parents.
    MeSH term(s) Adolescent ; Adult ; Blood Glucose Self-Monitoring ; Child ; Child, Preschool ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/psychology ; Fear ; Female ; Humans ; Hypoglycemia/etiology ; Hypoglycemia/psychology ; Hypoglycemic Agents/administration & dosage ; Insulin/administration & dosage ; Insulin Infusion Systems ; Male ; Parents/psychology ; Young Adult
    Chemical Substances Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2020-11-27
    Publishing country Denmark
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1502504-4
    ISSN 1399-5448 ; 1745-1426 ; 1399-543X
    ISSN (online) 1399-5448
    ISSN 1745-1426 ; 1399-543X
    DOI 10.1111/pedi.13150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Health-related Quality of Life in Children With Prune-belly Syndrome and Their Caregivers.

    Arlen, Angela M / Kirsch, Susan S / Seidel, Natan E / Garcia-Roig, Michael / Smith, Edwin A / Kirsch, Andrew J

    Urology

    2016  Volume 87, Page(s) 224–227

    Abstract: Objective: To compare health-related quality of life (HRQoL) in children with prune-belly syndrome (PBS) and their caregivers to healthy controls, as children and adolescents with PBS face numerous potential physical and psychosocial challenges.: ... ...

    Abstract Objective: To compare health-related quality of life (HRQoL) in children with prune-belly syndrome (PBS) and their caregivers to healthy controls, as children and adolescents with PBS face numerous potential physical and psychosocial challenges.
    Materials and methods: Study participants completed the Pediatric Quality of Life Inventory Generic Core Scales (PedsQL) 4.0 generic core scales (children) or Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF) (caregivers) in an online, anonymous format. The PedsQL 4.0 is a 23-item, age-adjusted, validated questionnaire that assesses physical, emotional, social, and school functioning in pediatric patients. The Q-LES-Q-SF is a validated, self-report measure that assesses various areas of daily functioning in adults.
    Results: PedsQL 4.0 was completed by 32 children with PBS. Individual physical (66.3 ± 20 vs 84.4 ± 17.3; P < .0001), emotional (68.4 ± 23.4 vs 80.9 ± 19.6; P < .01), social (63.1 ± 21.3 vs 87.4 ± 17.2; P  <  .0001), and school (53 ± 21.7 vs 78.6 ± 20.5; P < .0001) functioning scales were all significantly lower than in healthy children. Nineteen caregivers completed the Q-LES-Q-SF. Caregivers had a mean raw score of 54.8 ± 9.6, which was significantly lower (P  =  .02) than the comparative healthy adult cohort (59.8 ± 11.3).
    Conclusion: PBS profoundly impacts HRQoL in children, negatively affecting physical, emotional, social, and school functioning. Caregivers of PBS patients also report an overall lower quality of life, highlighting the challenges that families with chronically ill children often face.
    MeSH term(s) Adolescent ; Adult ; Caregivers/psychology ; Child ; Child, Preschool ; Emotions ; Female ; Follow-Up Studies ; Health Status ; Humans ; Male ; Prune Belly Syndrome/psychology ; Quality of Life ; Retrospective Studies ; Surveys and Questionnaires
    Language English
    Publishing date 2016-01
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 192062-5
    ISSN 1527-9995 ; 0090-4295
    ISSN (online) 1527-9995
    ISSN 0090-4295
    DOI 10.1016/j.urology.2015.09.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Imaging of SHOX-associated anomalies.

    Gahunia, Harpal K / Babyn, Paul S / Kirsch, Susan / Mendoza-Londono, Roberto

    Seminars in musculoskeletal radiology

    2009  Volume 13, Issue 3, Page(s) 236–254

    Abstract: Human growth is a multifactorial trait influenced by environmental, hormonal, and genetic factors. Although it is clear that multiple factors contribute to an individual's final height and limb development, genetic factors play a crucial role. One such ... ...

    Abstract Human growth is a multifactorial trait influenced by environmental, hormonal, and genetic factors. Although it is clear that multiple factors contribute to an individual's final height and limb development, genetic factors play a crucial role. One such gene is the short stature homeobox ( SHOX) containing gene. Knowledge about the SHOX gene has rapidly increased since its discovery in 1997, and we now know that SHOX haploinsufficiency affects the development of the extremities and is an important cause of short stature. Currently, SHOX mutations occur with an estimated incidence of roughly 1 in 1000 newborns, making mutations of this gene one of the most common genetic defects associated with growth failure and skeletal deformities. Heterozygous mutations of SHOX have been implicated in patients with Madelung's deformity, Leri-Weill dyschondrosteosis (77%), Turner's syndrome (66%), and idiopathic short stature (3%), and homozygous mutations of SHOX gene have been identified in patients with Langer's mesomelic dysplasia (100%). Recognition of the early radiographic features encountered in SHOX haploinsufficiency maybe pivotal for the diagnosis. In this article, we summarize the genetic and clinical features of the various SHOX haploinsufficiency-associated disorders. We present the characteristic imaging features of these disorders and the results of growth hormone treatment trials.
    MeSH term(s) Body Height/genetics ; Growth Disorders/diagnostic imaging ; Growth Disorders/genetics ; Haploidy ; Humans ; Limb Deformities, Congenital/genetics ; Radiography
    Language English
    Publishing date 2009-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1360919-1
    ISSN 1098-898X ; 1089-7860
    ISSN (online) 1098-898X
    ISSN 1089-7860
    DOI 10.1055/s-0029-1237691
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Phantom urinary incontinence in children with bladder-bowel dysfunction.

    Arlen, Angela M / Dewhurst, Liisa L / Kirsch, Susan S / Dingle, Arden D / Scherz, Hal C / Kirsch, Andrew J

    Urology

    2014  Volume 84, Issue 3, Page(s) 685–688

    Abstract: Objective: To report a previously undescribed condition in which children present with the sensation of wetness because of presumed urinary incontinence when they are actually completely dry. We have termed this entity "phantom" urinary incontinence ( ... ...

    Abstract Objective: To report a previously undescribed condition in which children present with the sensation of wetness because of presumed urinary incontinence when they are actually completely dry. We have termed this entity "phantom" urinary incontinence (PUI).
    Materials and methods: Twenty children referred to our pediatric urology clinic were diagnosed with PUI between 2009 and 2013. Patient demographics, associated bladder and bowel symptoms, concomitant diagnoses, imaging, management, and treatment outcomes were evaluated.
    Results: Twenty children (18 females and 2 males) were diagnosed with PUI over a 5-year interval. Mean age at diagnosis was 6.9 ± 2.5 years (range, 4-12 years). Nineteen patients (95%) had concomitant lower urinary tract symptoms, and all were also diagnosed with constipation. Urgency (75%) and frequency (50%) were the most common associated bladder symptoms. Of the 18 girls, 13 (72%) had associated vaginitis. Fourteen children (70%) carried a parent-reported diagnosis of obsessive-compulsive disorder or obsessive-compulsive disorder personality traits. Patients were managed with timed voiding, dietary modifications, and a bowel regimen. Ninety percent children experienced improvement of bladder-bowel dysfunction and resolution of PUI at a mean follow-up of 14.4 months.
    Conclusion: Children with PUI have a high incidence of obsessive-compulsive traits. Phantom incontinence as well as associated lower urinary tract symptoms resolve with adherence to a strict bladder-bowel regimen.
    MeSH term(s) Child ; Child, Preschool ; Enuresis/complications ; Enuresis/psychology ; Female ; Humans ; Incidence ; Male ; Obsessive-Compulsive Disorder/complications ; Rectal Diseases/complications ; Rectal Diseases/psychology ; Treatment Outcome ; Urinary Bladder/pathology ; Urinary Incontinence/complications ; Urinary Incontinence/psychology
    Language English
    Publishing date 2014-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 192062-5
    ISSN 1527-9995 ; 0090-4295
    ISSN (online) 1527-9995
    ISSN 0090-4295
    DOI 10.1016/j.urology.2014.04.046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study.

    Mahmud, Farid H / Clarke, Antoine B M / Joachim, Kariym C / Assor, Esther / McDonald, Charlotte / Saibil, Fred / Lochnan, Heather A / Punthakee, Zubin / Parikh, Amish / Advani, Andrew / Shah, Baiju R / Perkins, Bruce A / Zuijdwijk, Caroline S / Mack, David R / Koltin, Dror / De Melo, Emilia N / Hsieh, Eugene / Mukerji, Geetha / Gilbert, Jeremy /
    Bax, Kevin / Lawson, Margaret L / Cino, Maria / Beaton, Melanie D / Saloojee, Navaaz A / Lou, Olivia / Gallego, Patricia H / Bercik, Premysl / Houlden, Robyn L / Aronson, Ronnie / Kirsch, Susan E / Paterson, William G / Marcon, Margaret A

    Diabetes care

    2020  Volume 43, Issue 7, Page(s) 1553–1556

    Abstract: Objective: To describe celiac disease (CD) screening rates and glycemic outcomes of a gluten-free diet (GFD) in patients with type 1 diabetes who are asymptomatic for CD.: Research design and methods: Asymptomatic patients (8-45 years) were screened ... ...

    Abstract Objective: To describe celiac disease (CD) screening rates and glycemic outcomes of a gluten-free diet (GFD) in patients with type 1 diabetes who are asymptomatic for CD.
    Research design and methods: Asymptomatic patients (8-45 years) were screened for CD. Biopsy-confirmed CD participants were randomized to GFD or gluten-containing diet (GCD) to assess changes in HbA
    Results: Adults had higher CD-seropositivity rates than children (6.8% [95% CI 4.9-8.2%,
    Conclusions: CD is frequently observed in asymptomatic patients with type 1 diabetes, and clinical vigilance is warranted with initiation of a GFD.
    MeSH term(s) Adolescent ; Adult ; Asymptomatic Diseases ; Autoantibodies/analysis ; Autoantibodies/blood ; Biopsy ; Blood Glucose/analysis ; Blood Glucose/metabolism ; Blood Glucose Self-Monitoring ; Canada ; Celiac Disease/blood ; Celiac Disease/complications ; Celiac Disease/diagnosis ; Celiac Disease/diet therapy ; Child ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/diagnosis ; Diabetes Mellitus, Type 1/diet therapy ; Diet, Gluten-Free ; Female ; Humans ; Male ; Mass Screening ; Middle Aged ; Postprandial Period ; Serologic Tests ; Treatment Outcome ; Young Adult
    Chemical Substances Autoantibodies ; Blood Glucose
    Language English
    Publishing date 2020-04-28
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 441231-x
    ISSN 1935-5548 ; 0149-5992
    ISSN (online) 1935-5548
    ISSN 0149-5992
    DOI 10.2337/dc19-1944
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top